Tioma Therapeutics

Tioma Therapeutics is a biopharmaceutical company dedicated to the research and development of anti-cancer drugs, achieving anti-cancer effects by enhancing immunity, with a research focus on the immune checkpoint inhibitor antibody anti-CD47.